Literature DB >> 1508327

Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas.

U Syversen1, H L Waldum, D T O'Connor.   

Abstract

Chromogranin A (CgA) is a useful probe of human neuroendocrine neoplasia and exocytotic sympathoadrenal activity, but the application of CgA immunoassays has not been widespread because of limited availability of purified human CgA. Here we describe a rapid, high yield isolation of human CgA. After obtaining and lysing pheochromocytoma chromaffin granules, the soluble core proteins (chromogranins) were depleted of dopamine-beta-hydroxylase by passage over a concanavalin A-Sepharose affinity column, then lyophilized, resuspended in volatile buffer, and gel filtered on Sephacryl S-300. SDS-PAGE-analyzed column fractions contained homogeneous human CgA, which was verified structurally (N-terminal amino acid sequence) and immunologically (radioimmunoassay and immunoblot). The overall 22.6 mg yield of purified CgA represented 5.7% of the starting vesicle core protein. This preparation will be useful in evaluating the sympathoadrenal system and endocrine neoplasia in man.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508327     DOI: 10.1016/0143-4179(92)90052-x

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  3 in total

1.  Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.

Authors:  Karl Søndenaa; Jon Sen; Frank Heinle; Lars Fjetland; Einar Gudlaugsson; Unni Syversen
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

2.  Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Authors:  S K Mahata; D T O'Connor; M Mahata; S H Yoo; L Taupenot; H Wu; B M Gill; R J Parmer
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.

Authors:  R J Parmer; M Mahata; Y Gong; S K Mahata; Q Jiang; D T O'Connor; X P Xi; L A Miles
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.